Status:
COMPLETED
Psychological Intervention Mobile App for Patients With AML
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating the impact of a psychological intervention mobile application (app) on the quality of life, mood, and symptoms of patients with acute myeloid leukemia (AML).
Detailed Description
Patients with a new diagnosis of AML often confront a sudden and life-threatening diagnosis, requiring an immediate disruption of their life and an urgent 4-6 week hospitalization to initiate intensiv...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years).
- New diagnosis of acute myeloid leukemia.
- Admitted to Massachusetts General Hospital for intensive induction chemotherapy requiring 4-6-week hospitalization.
- The ability to provide informed consent.
- Ability to comprehend and speak English.
Exclusion
- Significant uncontrolled psychiatric disorder (psychotic disorder, bipolar disorder,
- Major depression) or other co-morbid disease (dementia, cognitive impairment), which the treating clinician believes prohibits the ability to participate in study procedures
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03372291
Start Date
September 1 2018
End Date
July 1 2024
Last Update
August 13 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02114
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114